DK4382A - Fremgangsmaade til fremstilling af stabile praeparater af levonantradol eller n-methyllevonantradol eller farmaceutisk acceptable syreadditionssalte deraf - Google Patents
Fremgangsmaade til fremstilling af stabile praeparater af levonantradol eller n-methyllevonantradol eller farmaceutisk acceptable syreadditionssalte deraf Download PDFInfo
- Publication number
- DK4382A DK4382A DK4382A DK4382A DK4382A DK 4382 A DK4382 A DK 4382A DK 4382 A DK4382 A DK 4382A DK 4382 A DK4382 A DK 4382A DK 4382 A DK4382 A DK 4382A
- Authority
- DK
- Denmark
- Prior art keywords
- methyllevonantradol
- levonantradol
- procedure
- acid addition
- addition salts
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Neurology (AREA)
- Otolaryngology (AREA)
- Hospice & Palliative Care (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/223,672 US4406888A (en) | 1981-01-09 | 1981-01-09 | Aqueous micellar solutions of levonantradol and N-methyllevonantradol and lyophilic forms thereof for reconstitution |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK4382A true DK4382A (da) | 1982-07-10 |
Family
ID=22837540
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK4382A DK4382A (da) | 1981-01-09 | 1982-01-08 | Fremgangsmaade til fremstilling af stabile praeparater af levonantradol eller n-methyllevonantradol eller farmaceutisk acceptable syreadditionssalte deraf |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US4406888A (da) |
| EP (1) | EP0056681A3 (da) |
| JP (1) | JPS57136512A (da) |
| AU (1) | AU528316B2 (da) |
| CA (1) | CA1172569A (da) |
| CS (1) | CS235524B2 (da) |
| DK (1) | DK4382A (da) |
| ES (1) | ES8304429A1 (da) |
| FI (1) | FI813969A7 (da) |
| GR (1) | GR76514B (da) |
| HU (1) | HU186462B (da) |
| IL (1) | IL64731A0 (da) |
| NO (1) | NO820045L (da) |
| NZ (1) | NZ199415A (da) |
| PH (1) | PH17593A (da) |
| PT (1) | PT74257B (da) |
| ZA (1) | ZA82118B (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE33239E (en) * | 1983-09-06 | 1990-06-26 | Farmaceutisk Laboratorium Ferring A/S | Packaged stable enema solution or suspension containing 5-aminosalicyclic acid |
| US4657900A (en) * | 1983-09-27 | 1987-04-14 | Rowell Laboratories | Pharmaceutical article of manufacture comprising a bisulfite stabilized aqueous solution of 5-aminosalicylic acid and method |
| GB9512854D0 (en) * | 1995-06-23 | 1995-08-23 | Wellcome Found | Novel formulation |
| RU2117481C1 (ru) * | 1997-07-15 | 1998-08-20 | Государственный научно-исследовательский институт органической химии и технологии | Анальгетическое средство и способ его приготовления |
| US8163797B2 (en) * | 2003-12-31 | 2012-04-24 | Actavis Elizabeth Llc | Method of treating with stable pravastatin formulation |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2391552A (en) * | 1942-02-25 | 1945-12-25 | Curtis David | Stabilized aromatic compounds |
| BE786427A (fr) * | 1971-07-19 | 1973-01-18 | Pfizer | Compositions aqueuses de doxycycline |
| SE7704749L (sv) * | 1976-05-17 | 1977-12-05 | Pfizer | Kinoliner och forfarande och mellanprodukter for framstellning derav |
| BE854655A (fr) | 1976-05-17 | 1977-11-16 | Pfizer | 9-hydroxyhexahydrobenzo (c) quinoleines et intermediaires de synthese |
| US4260764A (en) * | 1976-12-22 | 1981-04-07 | Pfizer Inc. | 9-Hydroxyoctahydrobenzo [C] quinolines and intermediates therefor |
| US4320124A (en) * | 1980-10-17 | 1982-03-16 | Pfizer Inc. | Composition for enhancing binding of a benzodiazepine to central benzodiazepine receptors and use thereof |
-
1981
- 1981-01-09 US US06/223,672 patent/US4406888A/en not_active Expired - Lifetime
- 1981-12-10 FI FI813969A patent/FI813969A7/fi not_active Application Discontinuation
-
1982
- 1982-01-04 HU HU8211A patent/HU186462B/hu unknown
- 1982-01-05 EP EP82300018A patent/EP0056681A3/en not_active Withdrawn
- 1982-01-06 NZ NZ199415A patent/NZ199415A/en unknown
- 1982-01-07 JP JP57001342A patent/JPS57136512A/ja active Pending
- 1982-01-07 CA CA000393740A patent/CA1172569A/en not_active Expired
- 1982-01-07 PH PH26711A patent/PH17593A/en unknown
- 1982-01-08 IL IL64731A patent/IL64731A0/xx unknown
- 1982-01-08 AU AU79404/82A patent/AU528316B2/en not_active Ceased
- 1982-01-08 ZA ZA82118A patent/ZA82118B/xx unknown
- 1982-01-08 GR GR66964A patent/GR76514B/el unknown
- 1982-01-08 CS CS82174A patent/CS235524B2/cs unknown
- 1982-01-08 DK DK4382A patent/DK4382A/da not_active Application Discontinuation
- 1982-01-08 ES ES508609A patent/ES8304429A1/es not_active Expired
- 1982-01-08 PT PT74257A patent/PT74257B/pt unknown
- 1982-01-08 NO NO820045A patent/NO820045L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0056681A2 (en) | 1982-07-28 |
| ES508609A0 (es) | 1983-03-01 |
| FI813969L (fi) | 1982-07-10 |
| HU186462B (en) | 1985-08-28 |
| ZA82118B (en) | 1982-11-24 |
| PT74257B (en) | 1984-05-29 |
| AU7940482A (en) | 1982-07-22 |
| CA1172569A (en) | 1984-08-14 |
| US4406888A (en) | 1983-09-27 |
| CS235524B2 (en) | 1985-05-15 |
| AU528316B2 (en) | 1983-04-21 |
| EP0056681A3 (en) | 1983-07-20 |
| IL64731A0 (en) | 1982-03-31 |
| NZ199415A (en) | 1985-04-30 |
| ES8304429A1 (es) | 1983-03-01 |
| JPS57136512A (en) | 1982-08-23 |
| FI813969A7 (fi) | 1982-07-10 |
| PH17593A (en) | 1984-10-02 |
| NO820045L (no) | 1982-07-12 |
| PT74257A (en) | 1982-02-01 |
| GR76514B (da) | 1984-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK74282A (da) | Fremgangsmaade til fremstilling af imidazodiazepiner eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK164450C (da) | Alkylsulfonamidophenylalkylaminer eller syreadditionssalte deraf, farmaceutiske formuleringer indeholdende saadanne forbindelser og fremgangsmaade til fremstilling af forbindelserne | |
| DK162714C (da) | Analogifremgangsmaade til fremstilling af glycinamidderivater eller syreadditionssalte deraf | |
| DK156720C (da) | Analogifremgangsmaade til fremstilling af benzazepinderivater eller fysiologisk acceptable syreadditionssalte deraf | |
| DK149895C (da) | Fremgangsmaade til fremstilling af alfa-aminoacylprolyl-ng-carboxy-argininaldehydderivater eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK445084D0 (da) | 6-flour-1,4-dihydro-4-oxo-7-substituerede piperazinylquinolin-3-carboxylsyrederivater, fremgangsmaade til fremstilling af samme og farcaceutiske sammensaetninger indeholdende samme | |
| DK217481A (da) | Fremgangsmaade til fremstilling af pyridoxinderivater eller syreadditionssalte deraf | |
| DK86193A (da) | Fremgangsmaade til fremstilling af trifluorbenzoesyrederivater | |
| DK157862C (da) | Analogifremgangsmaade til fremstilling af imidazolylphenylamidiner eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK151017C (da) | Analogifremgangsmaade til fremstilling af substituerede n-(4-indolyl-piperidino-alkyl)-benzimidazoloner eller fysiologisk acceptable syreadditionssalte deraf | |
| DK280282A (da) | Fremgangsmaade til fremstilling af farmaceutiske praeparater indeholdende ergotalkaloider | |
| DK51282A (da) | Fremgangsmaade til fremstilling af farmaceutiske praeparater | |
| DK159079A (da) | Fremgangsmaade til fremstilling af derivater af 4-amino-2-piperidinoquinazolin eller syreadditionssalte deraf | |
| DK164551C (da) | Analogifremgangsmaade til fremstilling af cyclohexylthienyleddikesyreamider eller fysiologisk taalelige syreadditionssalte deraf | |
| DK321482A (da) | Fremgangsmaade til fremstilling af 1-imidazolyl-2-phenyl-8-piperazinylphenoxy-octan-2-ol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK438482A (da) | Fremgangsmaade til fremstilling af indanderivater eller syreadditionssalte deraf | |
| DK152427C (da) | Analogifremgangsmaade til fremstilling af 4-thiomethylpyridinforbindelser eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK319982A (da) | Fremgangsmaade til fremstilling af bicykliske forbindelser eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK157023C (da) | Analogifremgangsmaade til fremstilling af imidazodiazepiner eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK160874C (da) | Analogifremgangsmaade til fremstilling af ergol-8-en- eller ergolinforbindelser eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK553982A (da) | Fremgangsmaade til fremstilling af omt-esterderivater eller syreadditionssalte deraf | |
| DK172479A (da) | Fremgangsmaade til fremstilling af n-alkenylmoranolinderivater eller syreadditionssalte deraf | |
| DK150481C (da) | Analogifremgangsmaade til fremstilling af 3',4'-dihydro-spiro-(imidazolidin-4,1'-(2'h)-naphthalen)-5-on eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK47681A (da) | Fremgangsmaade til fremstilling af farmaceutiske praeparater | |
| DK475783D0 (da) | Fremgangsmade til fremstilling af farmaceutiske praeparater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHB | Application shelved due to non-payment |